Sleep Disorders

>

Latest News

Solriamfetol Treatment Yields Cognitive Gains in Obstructive Sleep Apnea: Daily Dose / image credit: ©New Africa/AdobeStock
Solriamfetol Treatment Yields Cognitive Gains in Obstructive Sleep Apnea: Daily Dose

July 29th 2025

Your daily dose of the clinical news you may have missed.

FDA Clears Happy Ring for At-Home Diagnosis of Sleep Apnea and Insomnia / Image credit: ©MohamadFaisal/AdobeStock
FDA Clears Happy Ring for At-Home Diagnosis of Sleep Apnea and Insomnia

June 19th 2025

Eli Lilly Expands Zepbound Access with New Vial Doses, Self-Pay Savings / Image credit: ©Douglas/AdobeStock
Eli Lilly Expands Zepbound Access with New Vial Doses, Self-Pay Savings

February 26th 2025

Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor
Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor

January 17th 2025

FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea with Obesity
FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea with Obesity

December 20th 2024

More News

© 2025 MJH Life Sciences

All rights reserved.